Scrip Regulatory Affairs
Eucomed puts its cards on table over centralised medtech role
25 November 2011
Amanda Maxwell
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- EU medtech regulatory reform could involve unannounced notified body visits, greater transparency and tighter controls on Class III devices
- Medtech trade bodies on PIP breast implants: crisis is a result of criminal action, not inadequacy of regulations
- European Commission to propose leading role in new regulatory future for its expert devices group?
- Impact assessment for recast of EU device directives over; centralised agency outcomes narrow
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
